Company intelligence / Profile preview

Hemas Pharmaceuticals

Ownership: Private
Development stage: Other

Overview

Hemas Pharmaceuticals leads Sri Lanka’s pharmaceutical distribution market with over 60 years of experience. The company distributes pharmaceuticals, surgical products, diagnostics, and consumer healthcare products across more than 3,100 pharmacies island-wide. It has introduced over 100 new SKUs in recent years focusing on NCDs and essential surgery-related medicines. The business emphasizes quality assurance through ISO-certified processes and maintains partnerships with global pharma companies for contract manufacturing[1][5][6][8].

Therapeutic areas: PulmonologyCardiovascularOther
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Partnerships with over 50 global pharmaceutical principals for import/distribution/manufacturing contracts

Beyond the preview

Go deeper on Hemas Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemas Pharmaceuticals.

Explore the full profile